Finally, we tested the inclusion of second-line treatment (highly significant in the descriptive analysis) in our previously published model [ 17 ], which included an AMACR + PLIN1 genetic risk score as well as gender, age, stage, smoking status and metabolic health as predictor variables.
← all excerpts
Clinical features and lipid metabolism genes as potential biomarkers in advanced lung cancer.
1
—
—